Hikma Manages To Stay Flat In 2022 Despite Generics Pressures
Annual Results See Injectables And Brands Success Offsetting Struggling Generics Unit
Growing returns from injectables and brands are helping to balance downwards pressures on Hikma’s generics business • Source: Shutterstock 
